Literature DB >> 33443534

The role of EMT-related lncRNA in the process of triple-negative breast cancer metastasis.

Haomeng Zhang1, Jiao Wang2, Yulong Yin1, Qingjie Meng1, Yonggang Lyu1.   

Abstract

Triple-negative breast cancer (TNBC) is the most malignant and fatal subtype of breast cancer, which has characterized by negativity expression of ER, PR, and HER2. Metastasis is the main factor affecting the prognosis of TNBC, and the process of metastasis is related to abnormal activation of epithelial-mesenchymal transition (EMT). Recent studies have shown that long non-coding RNA (LncRNA) plays an important role in regulating the metastasis and invasion of TNBC. Therefore, based on the metastasis-related EMT signaling pathway, great efforts have confirmed that LncRNA is involved in the molecular mechanism of TNBC metastasis, which will provide new strategies to improve the treatment and prognosis of TNBC. In this review, we summarized many signal pathways related to EMT involved in the transfer process. The advances from the most recent studies of lncRNAs in the EMT-related signal pathways of TNBC metastasis. We also discussed the clinical research, application, and challenges of LncRNA in TNBC.
© 2021 The Author(s).

Entities:  

Keywords:  Epithelial-mesenchymal transition(EMT); Metastasis; Triple-negative breast cancer(TNBC); long non-coding RNA(LncRNA)

Mesh:

Substances:

Year:  2021        PMID: 33443534      PMCID: PMC7859322          DOI: 10.1042/BSR20203121

Source DB:  PubMed          Journal:  Biosci Rep        ISSN: 0144-8463            Impact factor:   3.840


  85 in total

1.  The Marine-Derived Oligosaccharide Sulfate MS80, a Novel Transforming Growth Factor β1 Inhibitor, Reverses Epithelial Mesenchymal Transition Induced by Transforming Growth Factor-β1 and Suppresses Tumor Metastasis.

Authors:  Ji Zhou; Wenjie You; Guangqiang Sun; Yixuan Li; Bi Chen; Jing Ai; Handong Jiang
Journal:  J Pharmacol Exp Ther       Date:  2016-07-18       Impact factor: 4.030

Review 2.  Everolimus.

Authors:  Jens Hasskarl
Journal:  Recent Results Cancer Res       Date:  2018

Review 3.  The Wnt/β-catenin signaling pathway: a potential therapeutic target in the treatment of triple negative breast cancer.

Authors:  Taj D King; Mark J Suto; Yonghe Li
Journal:  J Cell Biochem       Date:  2012-01       Impact factor: 4.429

4.  Triple negative breast cancer therapy with CDK1 siRNA delivered by cationic lipid assisted PEG-PLA nanoparticles.

Authors:  Yang Liu; Yan-Hua Zhu; Cheng-Qiong Mao; Shuang Dou; Song Shen; Zi-Bin Tan; Jun Wang
Journal:  J Control Release       Date:  2014-07-10       Impact factor: 9.776

Review 5.  Signaling mechanisms of the epithelial-mesenchymal transition.

Authors:  David M Gonzalez; Damian Medici
Journal:  Sci Signal       Date:  2014-09-23       Impact factor: 8.192

6.  Breast cancer statistics, 2017, racial disparity in mortality by state.

Authors:  Carol E DeSantis; Jiemin Ma; Ann Goding Sauer; Lisa A Newman; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2017-10-03       Impact factor: 508.702

7.  Wnt proteins are self-renewal factors for mammary stem cells and promote their long-term expansion in culture.

Authors:  Yi Arial Zeng; Roel Nusse
Journal:  Cell Stem Cell       Date:  2010-06-04       Impact factor: 24.633

Review 8.  New Insights into the Implication of Epigenetic Alterations in the EMT of Triple Negative Breast Cancer.

Authors:  Noura Khaled; Yannick Bidet
Journal:  Cancers (Basel)       Date:  2019-04-18       Impact factor: 6.639

Review 9.  Long Non-Coding RNA and Breast Cancer.

Authors:  Tianzhu Zhang; Hui Hu; Ge Yan; Tangwei Wu; Shuiyi Liu; Weiqun Chen; Yong Ning; Zhongxin Lu
Journal:  Technol Cancer Res Treat       Date:  2019-01-01

10.  Portraying breast cancers with long noncoding RNAs.

Authors:  Olivier Van Grembergen; Martin Bizet; Eric J de Bony; Emilie Calonne; Pascale Putmans; Sylvain Brohée; Catharina Olsen; Mingzhou Guo; Gianluca Bontempi; Christos Sotiriou; Matthieu Defrance; François Fuks
Journal:  Sci Adv       Date:  2016-09-02       Impact factor: 14.136

View more
  5 in total

1.  Development of a Prognostic Model Based on the Identification of EMT-Related lncRNAs in Triple-Negative Breast Cancer.

Authors:  Jiani Guo; Xuesong Yi; Zhuqing Ji; Mengchu Yao; Yu Yang; Wei Song; Mingde Huang
Journal:  J Oncol       Date:  2021-11-27       Impact factor: 4.375

Review 2.  The Role of Long Non-Coding RNAs (lncRNAs) in Female Oriented Cancers.

Authors:  Faiza Naz; Imran Tariq; Sajid Ali; Ahmed Somaida; Eduard Preis; Udo Bakowsky
Journal:  Cancers (Basel)       Date:  2021-12-03       Impact factor: 6.639

Review 3.  The Regulatory Functions and the Mechanisms of Long Non-Coding RNAs in Cervical Cancer.

Authors:  Qiwei Yang; Ayman Al-Hendy
Journal:  Cells       Date:  2022-03-29       Impact factor: 6.600

4.  LncRNA ENST869 Targeting Nestin Transcriptional Region to Affect the Pharmacological Effects of Chidamide in Breast Cancer Cells.

Authors:  Xiuyan Feng; Han Han; Yarui Guo; Xue Feng; Shanchun Guo; Weiqiang Zhou
Journal:  Front Oncol       Date:  2022-04-04       Impact factor: 5.738

Review 5.  Emerging role of lncRNAs in drug resistance mechanisms in head and neck squamous cell carcinoma.

Authors:  José A Peña-Flores; Mercedes Bermúdez; Rosalío Ramos-Payán; Carlos E Villegas-Mercado; Uriel Soto-Barreras; Daniela Muela-Campos; Alexis Álvarez-Ramírez; Brenda Pérez-Aguirre; Ana D Larrinua-Pacheco; César López-Camarillo; Jorge A López-Gutiérrez; Julio Garnica-Palazuelos; Marvin E Estrada-Macías; Juan L Cota-Quintero; Andrés A Barraza-Gómez
Journal:  Front Oncol       Date:  2022-08-01       Impact factor: 5.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.